[2602.13666] ALMo: Interactive Aim-Limit-Defined, Multi-Objective System for Personalized High-Dose-Rate Brachytherapy Treatment Planning and Visualization for Cervical Cancer
Summary
The article presents ALMo, an interactive system for personalized high-dose-rate brachytherapy treatment planning for cervical cancer, enhancing decision-making efficiency and treatment quality.
Why It Matters
ALMo addresses the complexities of clinical decision-making in brachytherapy by automating parameter setup and allowing clinicians to easily navigate treatment trade-offs. This innovation could lead to improved patient outcomes and reduced planning times, making it a significant advancement in cancer treatment technology.
Key Takeaways
- ALMo improves treatment planning efficiency, reducing average planning time from 30-60 minutes to approximately 17 minutes.
- The system allows clinicians to manipulate aim and limit values, enhancing the decision-making process in brachytherapy.
- In a study of 25 cases, ALMo achieved dosimetric improvements in 65% of treatments compared to manual planning.
- ALMo's optimization framework minimizes manual input, streamlining the planning process.
- The framework is applicable beyond brachytherapy, offering insights for multi-criteria clinical decision-making.
Computer Science > Machine Learning arXiv:2602.13666 (cs) [Submitted on 14 Feb 2026] Title:ALMo: Interactive Aim-Limit-Defined, Multi-Objective System for Personalized High-Dose-Rate Brachytherapy Treatment Planning and Visualization for Cervical Cancer Authors:Edward Chen, Natalie Dullerud, Pang Wei Koh, Thomas Niedermayr, Elizabeth Kidd, Sanmi Koyejo, Carlos Guestrin View a PDF of the paper titled ALMo: Interactive Aim-Limit-Defined, Multi-Objective System for Personalized High-Dose-Rate Brachytherapy Treatment Planning and Visualization for Cervical Cancer, by Edward Chen and Natalie Dullerud and Pang Wei Koh and Thomas Niedermayr and Elizabeth Kidd and Sanmi Koyejo and Carlos Guestrin View PDF HTML (experimental) Abstract:In complex clinical decision-making, clinicians must often track a variety of competing metrics defined by aim (ideal) and limit (strict) thresholds. Sifting through these high-dimensional tradeoffs to infer the optimal patient-specific strategy is cognitively demanding and historically prone to variability. In this paper, we address this challenge within the context of High-Dose-Rate (HDR) brachytherapy for cervical cancer, where planning requires strictly managing radiation hot spots while balancing tumor coverage against organ sparing. We present ALMo (Aim-Limit-defined Multi-Objective system), an interactive decision support system designed to infer and operationalize clinician intent. ALMo employs a novel optimization framework that minimizes man...